Related Experiment Video
Updated: Oct 16, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Hospitalization Burden and Incidence of Krabbe Disease
Gabrielle Ghabash1, Jacob Wilkes2, Bradley J Barney3
1University of Utah School of Medicine, Salt Lake City, UT, USA.
Objective:
The purpose of our study was to understand the healthcare burden and incidence of Krabbe disease (Krabbe).
Methods:
Retrospective analysis of Krabbe patients identified October 1, 2015 through December 31, 2020, ages birth through age 3, evaluated in two national databases. We estimated point prevalence and incidence from year 2016 data.
Results:
We identified 98 unique Krabbe patients with 736 visits including 260 were inpatient admissions. Total healthcare charges were $51.5 million dollars. We determined a point prevalence of 34 68 Krabbe patients in 2016 ages 0 3 years. This estimates a birth incidence of ~1 in 310,000 live births. Significance: Krabbe disease patients had over $51 million in health care charges and hundreds of hospitalizations. Estimated prevalence and birth incidence is similar to rates observed from newborn screening. Our findings show the tremendous health impacts of Krabbe disease, and provide guidance for efforts in screening and treatment planning.
More Related Videos
Related Concept Videos
Inborn Errors of Metabolism
Lysosomal Hydrolases
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...

